Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.
Zeitouni M, Dorvillius E, Sulman D, Procopi N, Beaupré F, Devos P, Barthélémy O, Rouanet S, Ferrante A, Chommeloux J, Hekimian G, Kerneis M, Silvain J, Montalescot G; ACTION Study Group.
Zeitouni M, et al. Among authors: devos p.
Am J Cardiovasc Drugs. 2024 Oct 21. doi: 10.1007/s40256-024-00683-z. Online ahead of print.
Am J Cardiovasc Drugs. 2024.
PMID: 39432228